Alan J. Moskowitz
Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center
Papers
2
Total Citations
156
H-Index
2
About
Alan J. Moskowitz is a leading health economist whose work centers on the economic evaluation of head and neck cancer treatments, with a particular focus on oropharyngeal carcinoma. His major contributions lie in rigorously quantifying the cost-effectiveness and patient-centered outcomes of emerging surgical techniques versus traditional therapies. In his landmark 2014 study, Moskowitz conducted a pioneering cost-utility analysis comparing transoral robotic surgery (TORS) to (chemo)radiotherapy for early T-classification oropharyngeal cancer, a paper that has garnered over 100 citations for establishing the economic framework for this clinical decision. Complementing this, his 2013 work on health state utilities—cited over 50 times—was instrumental in translating subjective quality-of-life impacts into quantifiable utility scores, enabling more precise economic comparisons. By integrating societal perspectives and patient preferences into his models, Moskowitz has provided clinicians and policymakers with essential data to balance treatment efficacy, cost, and quality of life. His research is notable for its methodological rigor and direct relevance to value-based healthcare, making him a key figure in the intersection of oncology and health economics.
Research Focus
Key Achievements
Top Papers
- 1
- 2